Conference

Abstract Submission

The 9th International Conference of The Royal Medical Services cordially invites you to submit abstracts for oral presentations.

Please read the following instructions carefully before submitting your abstract:

Abstracts Guidelines and Policies

  • Abstracts should be based on scientific research in a structured manner including Title, Objectives, Methodology, Results and Conclusions.
  • All abstracts should be submitted online through this website by filling the form below.
  • Authors' Names, Department(s) and Institutional Affiliation(s) should appear in the abstract form.
  • Notification of Receipt will be sent to the first Author by email within 48 Hours, please check your junk or spam folder for this receipt email.
  • Final decision on abstract acceptance or rejection will be sent to the same email.
  • Once Abstract is submitted, modifications are not possible.
  • The Speaker & co-authors of the accepted abstract should be registered in the conference and payment finalized prior to scheduling presentation in the Scientific Program.
  • Abstract can be used for publication purposes by the Royal Medical Services of Jordan (RMS) or the International Committee of Military Medicine (ICMM).
  • Authors of accepted Military Medicine abstracts must provide the Complete Text of the presentation, Illustrations and bibliography before scheduling the abstract in the conference program. These papers will be considered for publication in the ICMM Journal "International Review of the Armed Forces Medical Services" Unless published elsewhere.
  • The submission of an abstract implies your consent to publish it in the Abstract Book.
  • Title: The title should be as concise as possible.
  • Word Count: Abstracts are limited to 250 words not including spaces, with a structured format consisting of the introduction, methodology, results and conclusion with at least 3 keywords.
  • Abstract Body: Make abstracts as informative as possible, including a brief statement of the purpose of the study or why it was done, the methods used, the results observed, and the author(s)’ conclusions based upon the results. Actual data should be summarized. It is inadequate to state “the results will be discussed” or “the data will be presented.” Abstract in English.
    • Objectives: Clearly state the purpose of the abstract
    • Methodology: Describe your selection of observations or experimental subjects
    • Results and Discussion: Present your results in a logical sequence in text
    • Conclusion: Emphasize new and important aspects of the study and conclusions that are drawn from them
  • Do NOT use subtitles (e.g., Methods, Results) in the abstract body.
  • Do NOT include grant support information in the abstract body.
  • Do NOT enter author, title or grant information into the “Abstract Body” text box.
  • The use of standard abbreviations is requested. Examples include: kg, g, mg, ml, L (liter), mEq (milliequivalent), m (meter), mmol/L (millimoles per liter), / (per), and % (percent).
  • Place a special or unusual abbreviation in parentheses after the full word the first time it appears, and then use the abbreviation throughout the remainder of the abstract.
  • Use numerals to indicate numbers, except when beginning sentences.
  • Nonproprietary (generic) names should be the first name a drug is mentioned and type in lowercase letters, followed by the trade name in parentheses. Trade names are always capitalized. Example: aspirin (Bufferin).
  • When discussing therapeutic options, it is our preference that you use only generic names. If it is necessary to use a trade name, then those of several companies must be used. In addition, should your presentation include discussion of any unlabeled or investigational use of a commercial product, you are required to disclose this at the time of presentation.
  • Do NOT use tables and figures/illustrations, special symbols, charts, pictures or images as DOC, XLS, GIF, PNG, or JPG files.
  • Please use table/figure captions in the PPT presentation during the conference.


Flow of Submission

  • Abstract submission starts on 1 January 2018, and ends on 30 June 2018.
  • Please understand that should you have not completed the registration payment by 31 August 2018, the Scientific Committee has the right for not including your abstract in the conference.
  • Scientific Committee will review and evaluate submitted abstracts on strict double-blind policy according the aforementioned criteria for acceptance and presentation purposes in the conference scientific program and publishing in the Abstract Book. Acceptance notification will be sent to participants accordingly.


Presentation Guideline

Preparation for Oral Presentation

  1. Presentation Time: 10 minutes
  2. Internet access will NOT be provided in session rooms.
  3. Presentation slides should be prepared with MS Power point (PPT) version 2003 or higher.
  4. Presenters are requested to check and submit their final version of presentation files in the Speaker's Room 4 hours before their presentations. You should check your presentation file whether it works correctly in our system.
  5. Computers with Windows Operating System (no Apple or other Operating System) will be provided. You are requested to bring your own if you need to use other operating system.

 

Abstract Submission Applications

Abstract Title  
Speaker Name  
Status
Co-authors  
Job Details  
Email  
Phone  
Fax
Country
Abstract Details
Objectives  
 
Methodology  
 
Results and Discussion  
 
Conclusion  
 
Keywords